MyAverix Finance
US · Healthcare
NuCana PLC (NCNA)
Biotechnology
NuCana PLC (NCNA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NCNA
P/E ratio
25.00
NuCana PLC (NCNA) — FAQ
What is NCNA's P/E ratio?
The price-to-earnings (P/E) ratio for NuCana PLC (NCNA) is 25.00 (data as of 2026-05-23).
Does NuCana PLC pay a dividend?
Dividend yield is not available in the current snapshot for NuCana PLC (NCNA). Check the MyAverix Finance app for the latest dividend data.
What sector is NuCana PLC in?
NuCana PLC (NCNA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NCNA listed on?
NCNA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.